S. Ozcelik Et Al. , "Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience," ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1, pp.1-8, 2021
Ozcelik, S. Et Al. 2021. Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience. ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1 , 1-8.
Ozcelik, S., Celik, M., Vural, A., Aydin, B., Ozcelik, M., & GÖZÜ, H., (2021). Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience. ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1, 1-8.
Ozcelik, Serhat Et Al. "Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience," ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1, 1-8, 2021
Ozcelik, Serhat Et Al. "Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience." ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1, pp.1-8, 2021
Ozcelik, S. Et Al. (2021) . "Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience." ARCHIVES OF MEDICAL SCIENCE , vol.17, no.1, pp.1-8.
@article{article, author={Serhat Ozcelik Et Al. }, title={Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience}, journal={ARCHIVES OF MEDICAL SCIENCE}, year=2021, pages={1-8} }